Analysis of the effectiveness of second oral glucose-lowering therapy in routine clinical practice from the Mediterranean area: A retrospective cohort study

Type 2 diabetes mellitus (T2DM) is a heterogeneous condition characterized by progressive deterioration of glycaemic control that with time usually requires the combination of several antidiabetic drugs with different mechanisms of action. Additionally, T2DM carries a high risk for cardiovascular diseases (CVD) due to cardiovascular risk factors including overweight, hypertension, smoking, family history of premature coronary disease, chronic kidney disease, albuminuria and dyslipidaemia [1].

Source: Diabetes Research and Clinical Practice - December 10, 2020 Category: Endocrinology Authors: Bogdan Vlacho, Xavier Mundet-Tudur í, Manel Mata-Cases, Joan Antoni Vallès-Callol, Jordi Real, Magí Farré, Xavier Cos, Kamlesh Khunti, Dídac Mauricio, Josep Franch-Nadal Source Type: research